Literature DB >> 11333887

Herpes simplex virus type 1 corneal infection results in periocular disease by zosteriform spread.

B C Summers1, T P Margolis, D A Leib.   

Abstract

In humans and animal models of herpes simplex virus infection, zosteriform skin lesions have been described which result from anterograde spread of the virus following invasion of the nervous system. Such routes of viral spread have not been fully examined following corneal infection, and the possible pathologic consequences of such spread are unknown. To investigate this, recombinant viruses expressing reporter genes were generated to quantify and correlate gene expression with replication in eyes, trigeminal ganglia, and periocular tissue. Reporter activity peaked in eyes 24 h postinfection and rapidly fell to background levels by 48 h despite the continued presence of viral titers. Reporter activity rose in the trigeminal ganglia at 60 h and peaked at 72 h, concomitant with the appearance and persistence of infectious virus. Virus was present in the periocular skin from 24 h despite the lack of significant reporter activity until 84 h postinfection. This detection of reporter activity was followed by the onset of periocular disease on day 4. Corneal infection with a thymidine kinase-deleted reporter virus displayed a similar profile of reporter activity and viral titer in the eyes, but little or no detectable activity was observed in trigeminal ganglia or periocular tissue. In addition, no periocular disease symptoms were observed. These findings demonstrate that viral infection of periocular tissue and subsequent disease development occurs by zosteriform spread from the cornea to the periocular tissue via the trigeminal ganglion rather than by direct spread from cornea to the periocular skin. Furthermore, clinical evidence is discussed suggesting that a similar mode of spreading and disease occurs in humans following primary ocular infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11333887      PMCID: PMC114911          DOI: 10.1128/JVI.75.11.5069-5075.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Neuronal propagation of HSV1 from the oral mucosa to the eye.

Authors:  M Labetoulle; P Kucera; G Ugolini; F Lafay; E Frau; H Offret; A Flamand
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-08       Impact factor: 4.799

2.  Ocular pathogenicity of herpes simplex virus.

Authors:  T J Hill
Journal:  Curr Eye Res       Date:  1987-01       Impact factor: 2.424

3.  Efficacy of glycoprotein inhibitors alone and in combination with trifluridine in the treatment of murine herpetic keratitis.

Authors:  Y J Gordon; K P Cheng; T Araullo-Cruz; E Romanowski; B J Johnson; H A Blough
Journal:  Curr Eye Res       Date:  1986-02       Impact factor: 2.424

Review 4.  Zosteriform herpes simplex.

Authors:  W M Forrest; H E Kaufman
Journal:  Am J Ophthalmol       Date:  1976-01       Impact factor: 5.258

5.  Zosteriform spread of herpes simplex virus as a model of recrudescence and its use to investigate the role of immune cells in prevention of recurrent disease.

Authors:  A Simmons; A A Nash
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

6.  "Recurrent herpes zoster": an unproved entity?

Authors:  N S Heskel; J M Hanifin
Journal:  J Am Acad Dermatol       Date:  1984-03       Impact factor: 11.527

7.  Role of antibody in primary and recurrent herpes simplex virus infection.

Authors:  A Simmons; A A Nash
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

8.  Herpes simplex virus virion host shutoff (vhs) activity alters periocular disease in mice.

Authors:  T J Smith; C E Ackland-Berglund; D A Leib
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

9.  Pathogenesis of zosteriform spread of herpes simplex virus in the mouse.

Authors:  W A Blyth; D A Harbour; T J Hill
Journal:  J Gen Virol       Date:  1984-09       Impact factor: 3.891

10.  Ocular infection with herpes simplex virus in nonimmune and immune mice.

Authors:  A B Tullo; C Shimeld; W A Blyth; T J Hill; D L Easty
Journal:  Arch Ophthalmol       Date:  1983-06
View more
  35 in total

1.  Herpes simplex virus 1 ICP0 phosphorylation site mutants are attenuated for viral replication and impaired for explant-induced reactivation.

Authors:  Heba H Mostafa; Thornton W Thompson; Anna S Kushnir; Steve D Haenchen; Adam M Bayless; Joshua G Hilliard; Malen A Link; Lisa A Pitcher; Emma Loveday; Priscilla A Schaffer; David J Davido
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

2.  Herpes simplex virus type 1 origins of DNA replication play no role in the regulation of flanking promoters.

Authors:  Bretton C Summers; David A Leib
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

3.  Human cytomegalovirus inhibition by cardiac glycosides: evidence for involvement of the HERG gene.

Authors:  Arun Kapoor; Hongyi Cai; Michael Forman; Ran He; Meir Shamay; Ravit Arav-Boger
Journal:  Antimicrob Agents Chemother       Date:  2012-07-09       Impact factor: 5.191

Review 4.  Herpesvirus Entry Mediator and Ocular Herpesvirus Infection: More than Meets the Eye.

Authors:  Rebecca G Edwards; Richard Longnecker
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

5.  Construction and characterization of a herpes simplex virus type I recombinant expressing green fluorescent protein: acute phase replication and reactivation in mice.

Authors:  John W Balliet; Anna S Kushnir; Priscilla A Schaffer
Journal:  Virology       Date:  2007-01-17       Impact factor: 3.616

6.  Noninvasive bioluminescence imaging of herpes simplex virus type 1 infection and therapy in living mice.

Authors:  Gary D Luker; J Patrick Bardill; Julie L Prior; Christina M Pica; David Piwnica-Worms; David A Leib
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

7.  Bioluminescence imaging reveals systemic dissemination of herpes simplex virus type 1 in the absence of interferon receptors.

Authors:  Gary D Luker; Julie L Prior; Jiling Song; Christina M Pica; David A Leib
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

8.  Regulation of the catalytic activity of herpes simplex virus 1 protein kinase Us3 by autophosphorylation and its role in pathogenesis.

Authors:  Ken Sagou; Takahiko Imai; Hiroshi Sagara; Masashi Uema; Yasushi Kawaguchi
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

9.  Re-evaluating natural resistance to herpes simplex virus type 1.

Authors:  William P Halford; John W Balliet; Bryan M Gebhardt
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  Investigation of the mechanism by which herpes simplex virus type 1 LAT sequences modulate preferential establishment of latent infection in mouse trigeminal ganglia.

Authors:  Yumi Imai; Kathleen Apakupakul; Philip R Krause; William P Halford; Todd P Margolis
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.